In experiments with rats, the 'pill' lowered blood glucose levels almost as much as injected insulin. In fact, the effects of the 'pill' lasted longer than that of injected insulin, according to the study published in the American Chemical Society journal Biomacromolecules.
For years, researchers have sought a way to transform delivery of insulin therapy from a jab to a pill, but it has been a challenge.
The body's digestive enzymes that are so good at breaking down food also break down insulin before it can get to work.
To overcome these hurdles, researchers from the National Institute of Pharmaceutical Education and Research (NIPER) in Punjab, combined two approaches to shield insulin from the digestive enzymes and then get it into the blood.
The team, which included researchers Ashish Kumar Agrawal, Harshad Harde, Kaushik Thanki and Sanyog Jain, packaged insulin in tiny sacs made of lipids, or fats, called liposomes, which are already used in some treatments.
Then, they wrapped the liposomes in layers of protective molecules called polyelectrolytes.
To help these "layersomes" get absorbed into the bloodstream, they attached folic acid, a kind of vitamin B that has been shown to help transport liposomes across the intestinal wall into the blood.
An estimated 347 million people globally are living with diabetes, a condition where the body fails to utilise the ingested glucose properly.
This could be due to lack of the hormone insulin or because the insulin that is available is not working effectively.
Diabetics must test their blood sugar several times a day, and need insulin jabs for the rest of their lives in order to maintain adequate levels of the hormone.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
